2013”N@•Êû@V—̈æ•ÊÇŒóŒQƒVƒŠ[ƒY
ŒŒ‰tÇŒóŒQi‘æ2”ÅjIII
|‚»‚Ì‘¼‚ÌŒŒ‰tŽ¾Š³‚ðŠÜ‚ß‚Ä|
@ |
•W‘è |
ƒgƒbƒvƒI[ƒT[ |
•Å” |
@ | ˜•¶ | “c‘º@˜a•v | 1 |
VIIID | ŒŒðŒ`¬«Ž¾Š³ | @ | @ |
1 | æ“V«ŒŒðŒ`¬«Ž¾Š³ | @ | @ |
(1) | æ“V«ƒAƒ“ƒ`ƒgƒƒ“ƒrƒ“Œ‡–RÇ/•ªŽqˆÙíÇ | ’Ò@@@”£ | 13 |
(2) | æ“V«ƒvƒƒeƒCƒ“CŒ‡–RÇ/ˆÙíÇ | ŽR–{@WŽm | 17 |
(3) | æ“V«ƒvƒƒeƒCƒ“SŒ‡–RÇ/ˆÙíÇ | —é–Ø@GŽ¡ | 22 |
(4) | Šˆ«‰»ƒvƒƒeƒCƒ“C(APC)ƒŒƒWƒXƒ^ƒ“ƒX | ‚–Ø@—[Šó | 27 |
(5) | ƒvƒ‰ƒXƒ~ƒmƒQƒ“ƒAƒNƒ`ƒx[ƒ^ƒCƒ“ƒqƒrƒ^[1‰ßèÇ | ‰ª–{@‹Ms | 31 |
(6) | Hageman trait(‘æ‡]‡UˆöŽqŒ‡–RÇ) | ‚‹´@K”Ž | 35 |
(7) | ƒwƒpƒŠƒ“ƒRƒtƒ@ƒNƒ^[‡UŒ‡–RÇ | ’Ò@@@”£ | 40 |
2 | æ“V«”ñŒŒðŒ`¬«Ž¾Š³ | @ | @ |
@ | ü—nŒnˆÙíÇGæ“V«ƒvƒ‰ƒXƒ~ƒmƒQƒ“Œ‡–RÇ‚Ì•ªŽq•a‘Ô | ˆê£@”’’é | 44 |
3 | Œã“V«ŒŒðŒ`¬«Ž¾Š³ | @ | @ |
(1) | RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ | “nç²@r”V | 49 |
(2) | ‚‹ÃŒÅ‘æ‡ZˆöŽqŒŒÇ | ”öè@@Ži | 54 |
(3) | ‚ƒtƒBƒuƒŠƒmƒQƒ“ŒŒÇ | ‘åŽR@—zŽq | 59 |
IXD | ‘¢ŒŒŠíŽîᇂƗމŽ¾Š³ | @ | @ |
1 | œ‘‘B«Ž¾Š³ | @ | @ |
(1) | –«œ‘«”’ŒŒ•aŒQ | @ | @ |
1) | –«œ‘«”’ŒŒ•a | •½ûP@ŽåÅ | 67 |
2) | Ph‰A«–«œ‘«”’ŒŒ•a | ˆäŽR@@—@ | 73 |
(2) | –«D’†‹…«”’ŒŒ•a | •½ŽR@‘׶ | 77 |
(3) | –«DŽ_‹…«”’ŒŒ•aC”ñ“Á’èŒ^ | “c’†@G˜a | 80 |
(4) | ^«ÔŒŒ‹…‘‰ÁÇ(^«‘½ŒŒÇ) | ¬¼@‘¥•v | 83 |
(5) | Di Guglielmo ÇŒóŒQ(ÔŒŒ•aAÔ”’ŒŒ•a‚¨‚æ‚Ñ”’ŒŒ•a‚Ì•aŒ^ˆÚs) | •½ŽR@‘׶ | 91 |
(6) | “Á”«ŒŒ¬”ÂŒŒÇ | @ | @ |
1) | –{‘Ô«ŒŒ¬”ÂŒŒÇ | ‹T“c@‘ñ˜Y | 94 |
2) | Ph —z«–{‘Ô«ŒŒ¬”ÂŒŒÇ | ‹v•y–Ø—fŽq | 98 |
3) | Žá”NŒ^–{‘Ô«ŒŒ¬”ÂŒŒÇ | –k’†@@–¾ | 101 |
(7) | œ‘üˆÛÇ | @ | @ |
1) | ‹}«“Á”«œ‘üˆÛÇ | ‚¼@@‘× | 105 |
2) | Lymphoid myelofibrosis | “c’†@~Ži | 108 |
3) | Neutrophilic myelofibrosis | “c’†@~Ži | 110 |
4) | Œ´”«œ‘üˆÛÇ | •½ŽR@‘׶ | 112 |
5) | “ñŽŸ«œ‘üˆÛÇ | ²“¡@@•× | 116 |
2 | ”’ŒŒ•a | @ | @ |
(1) | ‹}«œ‘«”’ŒŒ•a | @ | @ |
1) | ”÷•ª‰»Œ^œ‘‰è‹…«”’ŒŒ•a(M0) | X@@@Œ[ | 120 |
2) | –¢•ª‰»Œ^œ‘‰è‹…«”’ŒŒ•a(M1) | ’†–q@@„ | 124 |
3) | •ª‰»Œ^‹}«œ‘‰è‹…«”’ŒŒ•a(M2) | Œ´“c@_Žj | 130 |
4) | ‹}«‘Oœ‘‹…«”’ŒŒ•a(M3) | ó–ì@@‹ | 134 |
5) | ‹}«œ‘’P‹…«”’ŒŒ•a(M4) | ²”Œ@‹±¹ | 138 |
6) | ‹}«’P‹…«”’ŒŒ•a(M5) | •ˆä@‘å‰ë | 142 |
7) | ‹}«Ô”’ŒŒ•a(M6) | ”g‘½@’qŽq | 146 |
8) | ‹Šj‰è‹…«”’ŒŒ•a(M7) | ¡¼@‘å‰î | 150 |
(2) | ‹}«ƒŠƒ“ƒp«”’ŒŒ•a | @ | @ |
1) | B×–E«‹}«ƒŠƒ“ƒp«”’ŒŒ•a | X’J@‹žŽq | 154 |
2) | T‘O‹ì×–E«‹}«ƒŠƒ“ƒp«”’ŒŒ•a | ‰ª–{@N—T | 159 |
(3) | –«ƒŠƒ“ƒp«”’ŒŒ•aŒQ | @ | @ |
1) | –«ƒŠƒ“ƒp«”’ŒŒ•a | –Ø@’è•v | 163 |
2) | ‘OƒŠƒ“ƒp‹…«”’ŒŒ•a | @ | @ |
‡@ | B×–E‘OƒŠƒ“ƒp‹…«”’ŒŒ•a | ‹´–{@—DŽq | 167 |
‡A | T×–E‘OƒŠƒ“ƒp‹…«”’ŒŒ•a | “à“c@—§g | 172 |
3) | –«T×–E«ƒŠƒ“ƒp«”’ŒŒ•a | –Ø@’è•v | 176 |
(4) | ”ñ’èŒ^”’ŒŒ•a‚¨‚æ‚Ñ“ÁŽêŒ^ | @ | @ |
1) | Lymphoproliferative disease of granular lymphocytes (LDGL) | ˆé•”@‘׎i | 181 |
2) | ¬lT×–E”’ŒŒ•a/ƒŠƒ“ƒpŽî | ’†–ì@L—º | 186 |
3) | HTLV-1 ‰A«¬lT×–E”’ŒŒ•a | ‰F“s‹{@äo | 190 |
4) | HTLV-1 ŠÖ˜AÒ‘Ç(HAM) | ŽR–ì@‰Ã‹v | 195 |
5) | Hairy cell leukemia(HCL —L–Ñ×–E«”’ŒŒ•a) | –ƒ¶@”Í—Y | 200 |
6) | ’†•_Œo”’ŒŒ•a | ŽRŒûrˆê˜N | 205 |
7) | ”ñ”’ŒŒ«”’ŒŒ•a | “¿‰i@Œ«Ž¡ | 209 |
8) | Mixed lineage leukemia/hybrid leukemia/biphenotypic leukemia | ¬ì@ˆê‰p | 214 |
9) | NK×–E«”’ŒŒ•a | ‰Í@@Œh¢ | 218 |
10) | ’áŒ`¬”’ŒŒ•a | àV“c@–¾‹v | 221 |
11) | DŽ_‹…«”’ŒŒ•a | XŽR@”üº | 224 |
12) | ‹}«D‰–Šî‹…«”’ŒŒ•a | ‹{“à@@ | 228 |
13) | Œ`Ž¿×–E”’ŒŒ•a | ‹{“à@@ | 232 |
14) | ‚‚·‚Ô‚èŒ^”’ŒŒ•a | ’·ˆä@ˆê_ | 236 |
15) | ƒŠƒ“ƒp«RŒ´—z«‹}«œ‘«”’ŒŒ•a | •Ÿ“‡@‘ì–ç | 239 |
16) | œ‘«RŒ´—z«‹}«ƒŠƒ“ƒp«”’ŒŒ•a | @ | @ |
‡@ | œ‘«RŒ´—z« B-ALL | •ŸŒ´@‹KŽq | 243 |
‡A | œ‘«RŒ´—z« T-ALL | •ŸŒ´@‹KŽq | 246 |
17) | “ñŽŸ«”’ŒŒ•a(Ž¡—Ê֘Aœ‘«Žîá‡) | ’©ˆä@—m» | 249 |
18) | Žîᎌ`¬Œ^‹}«œ‘«”’ŒŒ•a | @ | @ |
@ | œ‘‰è×–EŽî(—ÎFŽî) | ŽR”V“à@ƒ | 255 |
3 | œ‘ˆÙŒ`¬ÇŒóŒQ(MDS) | @ | @ |
(1) | •s‰ž«•nŒŒ„Ÿ‚»‚ÌŠT”O‚ÆÅ‹ß‚Ì’mŒ©„Ÿ | ‘剮•~ˆê”n | 257 |
(2) | 5q-ÇŒóŒQ | Ô‰H@‘åŒå | 261 |
(3) | “S‰è‹…«•nŒŒ(ˆâ“`«‚¨‚æ‚ÑMDS‚ÉŠÜ‚Ü‚ê‚È‚¢Œã“V«“S‰è‹…«•nŒŒ‚ðŠÜ‚Þ) | ˆÉ“¡@—ǘa | 265 |
(4) | ‰è‹…‘‰Á‚𔺂¤•s‰ž«•nŒŒ | ‘åê@—Œb | 269 |
(5) | ˆÚsŠú‰è‹…‘‰Á‚𔺂¤•s‰ž«•nŒŒ | ”–ˆä@‹IŽq | 273 |
(6) | –«œ‘’P‹…«”’ŒŒ•a | ‘Δn@GŽ÷ | 278 |
(7) | Žá”N«œ‘’P‹…«”’ŒŒ•a | ‹{“à@@ | 284 |
(8) | Ž¡—Ê֘Aœ‘ˆÙŒ`¬ÇŒóŒQ | ”nê@^‹I | 289 |
(9) | Trilineage myelodysplasia | •Ÿ“‡@‘ì–ç | 294 |
(10) | œ‘ˆÙŒ`¬ÇŒóŒQ‚ƖƉuˆÙí | ²X–Ø@Œõ | 298 |
4 | ˆ««ƒŠƒ“ƒpŽî | @ | @ |
(1) | HodgkinƒŠƒ“ƒpŽî | –؉º@’©”Ž | 302 |
(2) | ”ñHodgkin ƒŠƒ“ƒpŽî | @ | @ |
1) | ’ራ«“xƒŠƒ“ƒpŽî | @ | @ |
‡@ | ‚Ñ‚Ü‚ñ«¬ƒŠƒ“ƒp‹…«ƒŠƒ“ƒpŽî(–«ƒŠƒ“ƒp«”’ŒŒ•a) | ’†£@ˆê‘¥ | 306 |
‡A | àh–E«ƒŠƒ“ƒpŽî (grade 1-3A) | ŽRŒû@‘fŽq | 310 |
2) | ’†ˆ««“xƒŠƒ“ƒpŽî | @ | @ |
‡@ | àh–E«ƒŠƒ“ƒpŽîgrade3b(‘å×–EŒ^) | •x“c@’¼l | 314 |
‡A | ‚Ñ‚Ü‚ñ«‘å×–EB×–E«ƒŠƒ“ƒpŽî(DLBCL) | •x“c@’¼l | 317 |
‡B | ƒ}ƒ“ƒgƒ‹×–EƒŠƒ“ƒpŽî | ‹¾–¡@—Ç–L | 321 |
‡C | ––½«T×–EƒŠƒ“ƒpŽîA”ñ“ÁˆÙŒQ | V’Ã@@–] | 327 |
‡D | ŒŒŠÇ–Ɖu‰è‹…«T×–EƒŠƒ“ƒpŽî | “à“c@rŽ÷ | 331 |
3) | ‚ˆ««“xƒŠƒ“ƒpŽî | @ | @ |
‡@ | B-/T-ƒŠƒ“ƒp‰è‹…«”’ŒŒ•a/ƒŠƒ“ƒpŽî | ‰ª–{@¹—² | 335 |
‡A | Burkitt ƒŠƒ“ƒpŽî | @ | @ |
a | Burkitt ƒŠƒ“ƒpŽî | …–Ø–ž²‰› | 342 |
b | Burkitt ƒŠƒ“ƒpŽî‚ÆDLBCL‚Ì“Á’¥‚ð‚à‚Á‚½ƒŠƒ“ƒpŽî | …–Ø–ž²‰› | 348 |
4) | ‚»‚Ì‘¼‚̃Šƒ“ƒpŽî‚¨‚æ‚Ñ“ÁŽêŒ^ | @ | @ |
‡@ | Composite lymphoma,Discordant lymphoma | ¼”ö@—LŽi | 353 |
‡A | ”畆T×–EƒŠƒ“ƒpŽî | @ | @ |
a | ‹Û󑧓÷Ç | ²X–Ø@ƒ | 357 |
b | Sezary ÇŒóŒQ | ²X–Ø@ƒ | 365 |
‡B | LennertƒŠƒ“ƒpŽî | ’‡¼@‹M–ç | 370 |
‡C | T-zone lymphoma | ‘哇@Fˆê | 373 |
‡D | ߊO«•Ó‰‘уŠƒ“ƒpŽîF”S–ŒŠÖ˜AƒŠƒ“ƒp‘gD(MALT)ƒŠƒ“ƒpŽî | ‰ª–{@¹—² | 377 |
‡E | ˆóŠÂ×–EƒŠƒ“ƒpŽî | ‚Œ´@‘åŽu | 383 |
‡F | ŒŒŠÇ“à‘å×–EŒ^B×–EƒŠƒ“ƒpŽî | ‘哇@Fˆê | 386 |
‡G | Anaplastic large cell lymphoma | ’†àV@‰·Žq | 390 |
‡H | HIV ŠÖ˜AƒŠƒ“ƒpŽî | ‰iˆä@G˜a | 394 |
‡I | NK ×–EƒŠƒ“ƒpŽî | —é–Ø@—¥˜N | 399 |
‡J | Null ×–EƒŠƒ“ƒpŽî | —Ñ@@’B”V | 405 |
‡K | ––½«ƒÁƒÂT ×–EƒŠƒ“ƒpŽî | X@•‡”üŽq | 409 |
‡L | Sarcoidosis-lymphoma ÇŒóŒQ | ‹¾–¡@—Ç–L | 414 |
5 | ƒŠƒ“ƒpŽî‚ÆŠÓ•Ê‚·‚ׂ«Ž¾Š³ | @ | @ |
(1) | ‘gD‹…«‰óŽ€«ƒŠƒ“ƒp߉Š(‹e’r•a) | ŽÄ“c@—²•v | 418 |
(2) | ‘Sg«Castleman •a | Έä@‘׎q | 423 |
(3) | Rosai-Dorfman •a | ¬“‡@@Ÿ | 427 |
(4) | Piringer ƒŠƒ“ƒp߉Š | ¬“‡@@Ÿ | 430 |
(5) | ”畆—Ç«ƒŠƒ“ƒp‘BŽîÇ | ’†–ì@@‘n | 434 |
(6) | ‘½”«ƒŠƒ“ƒpƒ|ƒŠ[ƒvÇ | ’Ò‘º@GŽ÷ | 438 |
(7) | ƒŠƒ“ƒpŽî—l“÷‰èŽîÇ | ˆÉ’O^‹IŽq | 443 |
6 | ‘gD‹…‘B«Ž¾Š³ | @ | @ |
(1) | ”½‰ž«ŒŒ‹…æÃH«‘gD‹…Ç | @ | @ |
1) | ‰Æ‘°«ŒŒ‹…æÃH«ƒŠƒ“ƒp‘gD‹…Ç | Έä@žÄˆê | 447 |
2) | Acute lupus hemophagocytic syndrome | –쑺@¹ì | 451 |
3) | ˆ««Žîᇊ֘AŒŒ‹…æÃHÇŒóŒQ | –쑺@¹ì | 454 |
4) | Ž©ŒÈ–ƉuŠÖ˜AŒŒ‹…æÃHÇŒóŒQ | ŒF‘q@rˆê | 457 |
5) | Bacteria-associated hemophagocytic syndrome | ìŒû@—T”V | 461 |
6) | Virus-associated hemophagocytic syndrome | ìŒû@—T”V | 466 |
(2) | Malignant histiocytosis ‚ÆŠÖ˜AŽ¾Š³ | @ | @ |
1) | ˆ««‘gD‹…Ç(‘gD‹…«‘—l×–ÔÇ)/‘gD‹…‚¨‚æ‚ÑŽ÷ó×–EŽîᇠ| ‘哇@Fˆê | 470 |
2) | Langerhans cell histiocytosis(histiocytosis X) | @ | @ |
‡@ | DŽ_‹…«“÷‰èŽîÇ | ‰£@^‹| | 474 |
‡A | Hand-Schuller-Christian ÇŒóŒQ | ‰£@^‹| | 479 |
‡B | Letterer-Siwe •a | ‰£@^‹| | 483 |
(3) | ƒŠƒsƒh[ƒVƒX | @ | @ |
1) | Gaucher •a | ˆä“c@”ŽK | 487 |
2) | Niemann-Pick •a | ‚‹´@@•× | 491 |
3) | Tay-Sachs •a | —¢@@—´° | 495 |
4) | Wolman •a | Š£@‚ ‚â‚Ì | 500 |
5) | Fabry •a | ”óŒû@ŒöŽk | 504 |
6) | ƒÀ-ƒKƒ‰ƒNƒgƒVƒ_[ƒ[Œ‡‘¹Ç(GM1-ƒKƒ“ƒOƒŠƒIƒVƒh[ƒVƒX,ƒ‚ƒ‹ƒLƒIB•a‚È‚Ç) | “ï”g@‰h“ñ | 507 |
7) | ŒŒ‹…æÃH‚𔺂¤Ž‰–bD‰Š | ŽOX@–¾•v | 511 |
8) | Weber-Christian •a | “ì‰Æ@—R‹I | 514 |
XD | ŒŒŸ÷ƒ^ƒ“ƒpƒN‚̈Ùí | @ | @ |
1 | ‘½”«œ‘Žî | @ | @ |
(1) | ’èŒ^œ‘Žî | @ | @ |
1) | ‘½”«œ‘Žî | @ | @ |
‡@ | IgGŒ^œ‘Žî | Îì@G–¾ | 519 |
‡A | IgAŒ^œ‘Žî | Îì@G–¾ | 530 |
‡B | BJPŒ^œ‘Žî | Îì@G–¾ | 532 |
‡C | IgDŒ^œ‘Žî | Îì@G–¾ | 534 |
‡D | IgMŒ^‘½”«œ‘Žî | ’r“c@@”Ž | 536 |
‡E | IgEŒ^‘½”«œ‘Žî | ’r“c@@”Ž | 539 |
2) | ŒÇ—§«Œ`Ž¿×–EŽî | ’|‰º@¹F | 542 |
3) | ‘ŠO«Œ`Ž¿×–EŽî | ’|‰º@¹F | 545 |
(2) | ”ñ’èŒ^œ‘Žî | @ | @ |
1) | ‚‚·‚Ô‚èŒ^‘½”«œ‘Žî | Œ´“c@•Žu | 548 |
2) | Œ€ÇŒ^‘½”«œ‘Žî | ˆÀ”{@³”Ž | 553 |
3) | ”ñ•ª”åŒ^E”ñŽY¶Œ^œ‘Žî | ‹àX@•½˜a | 557 |
4) | Žîᎌ`¬«‘½”«œ‘Žî | ¬ì@‘å•ã | 561 |
5) | ƒAƒ~ƒ‰[ƒ[ŽY¶‘½”«œ‘Žî | ¼‰º@ÍŽq | 564 |
6) | Neuron specific enolase ŽY¶‘½”«œ‘Žî | ²“¡@ˆê–ç | 569 |
7) | •¡M¬•ªŒ^‘½”«œ‘Žî | i“¡@Šî”Ž | 574 |
8) | ‚ƒAƒ“ƒ‚ƒjƒAŒŒÇ‚𔺂¤‘½”«œ‘Žî | ˜aò@@“§ | 578 |
2 | Œ´”«ƒ}ƒNƒƒOƒƒuƒŠƒ“ŒŒÇ‚Æ—Þ‰Ž¾Š³ | @ | @ |
(1) | Œ´”«ƒ}ƒNƒƒOƒƒuƒŠƒ“ŒŒÇ | ‚¼@@‘× | 581 |
(2) | ”’ŒŒ«ƒ}ƒNƒƒOƒƒuƒŠƒ“ŒŒÇ | Ÿ‰®@O—Y | 585 |
(3) | ŒÀ‹Ç«Œ´”«ƒ}ƒNƒƒOƒƒuƒŠƒ“ŒŒÇ | “c’†@r—T | 589 |
(4) | X˜A½«‚ IgM ÇŒóŒQ | Î’Ë@Œ«Ž¡ | 593 |
3 | H½•a | “c’†@FK | 597 |
4 | œ‘ŽîŠÖ˜AŽ¾Š³ | @ | @ |
(1) | Monoclonal gammopathy of undetermined significance(MGUS) | ’†‘º@—Tˆê | 601 |
(2) | POEMSÇŒóŒQ | ”¨@@—T”V | 606 |
(3) | œ‘Žît | ŽÄ“c@Š²Žq | 609 |
(4) | œ‘Žî‚É”º‚¤ƒAƒ~ƒƒCƒh[ƒVƒX | ”¨@@—T”V | 613 |
5 | ƒAƒ~ƒƒCƒh[ƒVƒX | @ | @ |
(1) | ‘Sg«ƒAƒ~ƒƒCƒh[ƒVƒX | @ | @ |
1) | Œ´”«ALƒAƒ~ƒƒCƒh[ƒVƒX | ŽR–{@—CŽ÷ | 615 |
2) | “ñŽŸ«ƒAƒ~ƒƒCƒh[ƒVƒX(AAƒAƒ~ƒƒCƒh[ƒVƒX) | –씨@GM | 620 |
3) | ˆâ“`«ƒAƒ~ƒƒCƒh[ƒVƒX | @ | @ |
‡@ | ‰Æ‘°«ƒAƒ~ƒƒCƒhƒ|ƒŠƒjƒ…[ƒƒpƒ`[ | ¬’r@tŽ÷ | 625 |
‡A | ‰Æ‘°«’n’†ŠC”M | •xŠ~@@Œ« | 630 |
4) | “§ÍƒAƒ~ƒƒCƒh[ƒVƒX | ²ˆä(›Á)‹g‰i | 635 |
(2) | ‹ÇŠ«ƒAƒ~ƒƒCƒh[ƒVƒX | @ | @ |
1) | ŒÀ‹Ç«Œ‹ß«”xƒAƒ~ƒƒCƒh[ƒVƒX | ‹àX@ÖC | 640 |
2) | SƒAƒ~ƒƒCƒh[ƒVƒX | ¬ŽR@@ | 644 |
3) | ”]ƒAƒ~ƒƒCƒh[ƒVƒX | H“¡@KŽi | 648 |
4) | ”畆ƒAƒ~ƒƒCƒh[ƒVƒX | •“¡@³•F | 653 |
6 | ƒNƒŠƒIƒOƒƒuƒŠƒ“ŒŒÇ | ‘ºã@”Ž˜a | 657 |
7 | ‚ƒÁƒOƒƒuƒŠƒ“ŒŒÇ | @ | @ |
(1) | ‚ƒÁƒOƒƒuƒŠƒ“ŒŒÇ«Ž‡”Á•a | ŽR”V“à@ƒ | 666 |
(2) | ‘½ƒNƒ[ƒ“«‚ƒÁƒOƒƒuƒŠƒ“ŒŒÇ | ‹v•Û“c–õŽq | 669 |
(3) | IgM Œ^—Ç«ƒÁƒOƒƒuƒŠƒ“ŒŒÇ | ‹v•Û“c–õŽq | 673 |
(4) | Biclonal gammopathy | ‹v•Û“c–õŽq | 676 |
8 | ‚»‚Ì‘¼‚ÌŒŒŸ÷ƒ^ƒ“ƒpƒN‚̈Ùí | @ | @ |
(1) | IgG3Œ‡‘¹Ç | —L‰ê@@³ | 679 |
(2) | ‚ƒÀ2 ƒ~ƒNƒƒOƒƒuƒŠƒ“ŒŒÇ | ‰œ–ì@@–L | 682 |
(3) | æ“V«ƒÀƒŠƒ|ƒ^ƒ“ƒpƒNŒ‡‘¹Ç(Bassen-Kornzweig ÇŒóŒQ) | ”ª”¦@‹`l | 686 |
(4) | Tangier •a(‰Æ‘°«’áHDLŒŒÇ) | ŽR“c@•ä‚ | 690 |
(5) | ƒAƒ‹ƒuƒ~ƒ“ˆÙí | @ | @ |
1) | æ“V«–³ƒAƒ‹ƒuƒ~ƒ“ŒŒÇ | ùŒ´@—m“ñ | 695 |
2) | ƒAƒƒAƒ‹ƒuƒ~ƒ“ŒŒÇ | ùŒ´@—m“ñ | 699 |
3) | Œã“V«’áƒAƒ‹ƒuƒ~ƒ“ŒŒÇ | “c’†@@Œõ | 702 |
(6) | IgG4 ŠÖ˜AŽ¾Š³ | ³–Ø@NŽj | 707 |
XID | ‚»‚Ì‘¼ | @ | @ |
1 | ŠC‘gD‹…ÇŒóŒQ(sea-blue histiocyte ÇŒóŒQ) | •½ŽR@‘׶ | 715 |
2 | Sweet ÇŒóŒQ | –kŒ´@M‰î | 718 |
3 | Systemic capillary leak syndrome(‘Sg«–Ñ׌ŒŠÇ˜RoÇŒóŒQ) | ’†Œ³@G—F | 721 |
4 | Tn ÇŒóŒQ | ‹Tè@–LŽÀ | 729 |
5 | L½’¾’…Ç | ¬™@_Žj | 733 |
6 | Œã“V«ŒŒðŒXŒü | ’©‘q@‰pô | 736 |
7 | •êŽ™ŠÔ—AŒŒÇŒóŒQ‚Æ‘ÙŽ™ŠÔ—AŒŒÇŒóŒQ | ‹à™@’mé | 741 |
8 | ‘¢ŒŒŠ²×–EˆÚA‚É‚¨‚¯‚鶒…ÇŒóŒQ | ‘唨@‹Ó–ç | 746 |
9 | ‹}«E–«GVHD | ‰Ÿì@@Šw | 750 |
10 | —AŒŒŒãˆÚA•Ð‘ÎhŽå•a(—AŒŒŒãGVHD) | “yŠò@“TŽq | 755 |
11 | ‚ŒŒ‰t”S“xÇŒóŒQ | ^•”@@~ | 758 |
12 | ‘¢ŒŒŠ²×–EˆÚA‚É‚¨‚¯‚éthrombotic microangiopathy | ã“c@—¢”ü | 763 |